Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle
- PMID: 2506214
- DOI: 10.1210/jcem-69-4-804
Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle
Abstract
The recurrent deficiency of progesterone (P) secretion by the corpus luteum has been associated with infertility and habitual abortion and given the clinical diagnosis of luteal phase deficiency (LPD). There is evidence that both follicular and luteal phase abnormalities can result in LPD cycles. In this study we have examined reproductive hormone levels and preovulatory follicular size in women with LPD (n = 10). For the purposes of this study, LPD was determined by an endometrial biopsy in the studied cycle that was more than 2 days out of phase. These biopsies were performed in women with infertility or habitual abortion who exhibited an out of phase biopsy in a prior cycle. The control group consisted of 28 normal women. Daily serum levels of the following hormones were determined in each subject: LH and FSH [immuno- and bioactive (LH-immuno and LH-bio)], P, estradiol (E2), and inhibin. The LPD women exhibited significant decreases in integrated luteal phase levels of inhibin [10,615 +/- 898 vs. 13,560 +/- 662 (U/L).days; P less than 0.02] and E2 [5,015 +/- 275 vs. 6,435 +/- 393 (pmol/L).days (1366 vs. 1753 (pg/mL).days); P less than 0.05] in addition to the expected decrease in P [280 +/- 23 vs. 420 +/- 23 (nmol/L).days (88 vs. 132 (ng/mL).days); P less than 0.01]. On days 6-11 after the LH surge (day 0), there was a significant (P less than 0.05) decrease in mean LH-bio levels in LPD compared with those in normal women (146 +/- 26 vs. 212 +/- 24 micrograms/L). The midcycle LH surge was deficient in LPD when both LH-immuno [482 +/- 30 vs. 672 +/- 43 (micrograms/L).days; P less than 0.01] and LH-bio [1711 +/- 179 vs. 2248 +/- 226 (micrograms/L).days; P less than 0.05] levels were compared with normal values. When comparing the follicular phase in LPD with that in normal women, similar follicle size, peak and integrated E2 levels, and mean LH and FSH (immuno and bio) levels were found. The only follicular phase abnormality noted in this study was decreased mean levels of serum inhibin in the early and midfollicular phases (221 +/- 19 vs. 308 +/- 25 U/L; P less than 0.01). In this group of women with LPD, low levels of inhibin in the follicular phase were consistent with the concept of a defect in function of the preovulatory follicle, possibly as a result of previously described defects in gonadotropin secretion in this condition.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Luteal phase defect: myth or reality.Obstet Gynecol Clin North Am. 2004 Dec;31(4):727-44, ix. doi: 10.1016/j.ogc.2004.08.007. Obstet Gynecol Clin North Am. 2004. PMID: 15550332 Review.
-
The diagnosis of luteal phase deficiency: a critical review.Fertil Steril. 1988 Jul;50(1):1-15. doi: 10.1016/s0015-0282(16)59999-3. Fertil Steril. 1988. PMID: 3289975 Review.
-
Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.J Clin Endocrinol Metab. 1987 Sep;65(3):457-64. doi: 10.1210/jcem-65-3-457. J Clin Endocrinol Metab. 1987. PMID: 3114301
-
Luteal phase deficiency: abnormal gonadotropin and progesterone secretion patterns.J Clin Endocrinol Metab. 1989 Oct;69(4):813-20. doi: 10.1210/jcem-69-4-813. J Clin Endocrinol Metab. 1989. PMID: 2506215
-
Prolactin secretion and corpus luteum function in women with luteal phase deficiency.J Clin Endocrinol Metab. 1991 May;72(5):986-92. doi: 10.1210/jcem-72-5-986. J Clin Endocrinol Metab. 1991. PMID: 2022718
Cited by
-
The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review.Cureus. 2023 Nov 3;15(11):e48194. doi: 10.7759/cureus.48194. eCollection 2023 Nov. Cureus. 2023. PMID: 38050524 Free PMC article. Review.
-
Postpartum ovulation and early pregnancy in the menstruating spiny mouse, Acomys cahirinus.Sci Rep. 2021 Mar 5;11(1):5344. doi: 10.1038/s41598-021-84361-z. Sci Rep. 2021. PMID: 33674629 Free PMC article.
-
Comparing cervical mucus changes in response to an oral progestin or oestrogen withdrawal in ovarian-suppressed women: a clinical pilot.Eur J Contracept Reprod Health Care. 2019 Jun;24(3):209-215. doi: 10.1080/13625187.2019.1605503. Epub 2019 May 8. Eur J Contracept Reprod Health Care. 2019. PMID: 31066303 Free PMC article.
-
Current Status of the Female Athlete Triad: Update and Future Directions.Curr Osteoporos Rep. 2017 Dec;15(6):577-587. doi: 10.1007/s11914-017-0412-x. Curr Osteoporos Rep. 2017. PMID: 29027102 Review.
-
Fractalkine restores the decreased expression of StAR and progesterone in granulosa cells from patients with polycystic ovary syndrome.Sci Rep. 2016 Jul 8;6:26205. doi: 10.1038/srep26205. Sci Rep. 2016. PMID: 27386819 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical